bèta
Trial Radar AI
De klinische studie NCT06744491 (NFRF) voor Lichamelijke inactiviteit, Veroudering, Gezond ouder worden, Growth & Development, Seksverschillen, Anabolic Sensitivity, Protein Metabolism, Lichamelijke activiteit is nog niet rekruterend. Bekijk de kaartweergave van de Klinische Studies Radar en de AI-ontdekkingstools voor alle details. Of stel hier een vraag.
Eén studie komt overeen met de filtercriteria
Kaartweergave

Oral 'Breath Test' to Measure Anabolic Sensitivity to a Protein Meal Across the Age and Physical Activity Spectrum (NFRF)

Nog niet rekruterend
Informatie over klinische studies is voornamelijk in het Engels beschikbaar. Trial Radar AI kan echter helpen! Klik op 'Leg studie uit' om de informatie over de studie te bekijken en te bespreken in de taal van uw keuze.
De klinische studie NCT06744491 (NFRF) is een observationeel studie bij Lichamelijke inactiviteit, Veroudering, Gezond ouder worden, Growth & Development, Seksverschillen, Anabolic Sensitivity, Protein Metabolism, Lichamelijke activiteit met de status nog niet rekruterend. De inclusie van 80 deelnemers start op 20 december 2024. De studie wordt geleid door de Universiteit van Toronto en de voltooiing is gepland op 31 augustus 2025. Laatste update op ClinicalTrials.gov: 20 december 2024.
Beknopte samenvatting
The purpose of this study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan, between biological sexes, and with varying physical activity levels.
Uitgebreide beschrijving
Skeletal muscle is a dynamic tissue that responds to anabolic (i.e., growth) stimuli such as protein ingestion and exercise. Differences in age and physical activity levels will influence an individual's ability to respond to these anabolic stimuli; this concept is known as anabolic sensitivity. For instance, older and less physically active individuals will display lower anabolic sensitivity (i.e., anabolic resistance) to a bout of exercise or the consumption of protein in comparison to younger, more physically active individuals. Seeing that individuals with anabolic resistance are at a greater risk for losing muscle mass over time, it is important to understand the anabolic sensitivity/resistance of an individual to assess for the efficiency of growth across the health and lifespan, in addition to a potential screen for metabolic alterations that could manifest into changes in lean body and muscle mass.

Traditional methods to assess for skeletal muscle anabolism and protein metabolism requires in-person and invasive research methods (i.e., stable isotope infusions and muscle biopsies) in controlled laboratory or clinical settings. However, there are many risks associated with these invasive procedures and they are not always feasible in all populations (e.g., children, clinical populations, etc..). Our lab has recently developed a non-invasive 13C breath test which employs an oral stable isotope tracer. Our breath test allows us to assess for anabolic sensitivity in response to protein ingestion, by determining how much of the ingested protein was used to build (synthesize) new proteins in our body (i.e., anabolism) or used as a source of energy (through a process called oxidation). As such, the purpose of the present study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan and with varying physical activity levels.

Officiële titel

Anabolic Sensitivity Across the Lifespan

Aandoeningen
Lichamelijke inactiviteitVerouderingGezond ouder wordenGrowth & DevelopmentSeksverschillenAnabolic SensitivityProtein MetabolismLichamelijke activiteit
Andere studie-ID's
  • NFRF
  • 00044004
NCT-ID
Startdatum (Werkelijk)
2024-12-20
Laatste update geplaatst
2024-12-20
Verwachte einddatum
2025-08-31
Inschrijving (Geschat)
80
Studietype
Observationeel
Status
Nog niet rekruterend
Trefwoorden
anabolic sensitivity
aging
growth and development
physical activity
skeletal muscle
stable isotopes
Armen / Interventies
Deelnemersgroep/StudiearmInterventie/Behandeling
Children
Children as defined by maturity offset via age from peak height velocity (aPHV \< -1.0 years).
N.v.t.
Adolescent
Adolescents as defined by maturity offset via age from peak height velocity (aPHV -0.5 to +1.5 years)
N.v.t.
Young Adults
Young adults as defined by chronological age between ages 18 - 35 years
N.v.t.
Older Adults
Older adults as defined by chronological age between ages 60 - 80 years
N.v.t.
Primaire uitkomst
UitkomstmaatBeschrijving van de uitkomstmaatTijdsbestek
Amino acid oxidation and net protein balance
Amino acid oxidation and net protein balance assessed by oral 1-13C Leucine tracer. Net protein balance is derived from the difference between amino acid intake (known) and total amino acid oxidation over the 6h post-prandial measurement period.
6 Hours
Geschiktheidscriteria

Leeftijd van deelnemers
Kind, Volwassene, Oudere volwassene
Minimumleeftijd
8 Years
Geslachten die in aanmerking komen voor de studie
Allen
Accepteert gezonde vrijwilligers
Ja
  • Healthy will be defined as screened by the PAR-Q+ (The Physical Activity Readiness Questionnaire for everyone)
  • Chronological age for Healthy Young (age: 18-35 years) or Older (age: 60-80 years) adults
  • Chronological age between 8 to 16 years, with maturity offset < -1 year from age of Peak Height Velocity (aPHV) for children and between -0.5 to +1.5 years from aPHV in adolescent participants
  • BMI between normal to overweight (18.5 - 29.9 kg/m2)

  • Regular use of nonsteroidal anti-inflammatory dugs (with the exception of daily low-dose aspirin)
  • use of anticoagulants
  • use of a walker, cane, or assistive walking device
  • infectious or gastrointestinal disease
  • inability to comply with study protocol (e.g., unable to track diet)
  • regular tobacco use
  • self-reported illicit drug use (e.g., growth hormone, testosterone, etc.)
  • diagnosed chronic illness (e.g., type 2 diabetes, heart disease, thyroid disease)
  • pregnant
  • hormonal replacement therapy
Verantwoordelijke instantie
Daniel Moore, Hoofdonderzoeker, Professor, Muscle Physiology, University of Toronto
Centraal Contactpersoon
Contact: Daniel R Moore, PhD, 4169464088, [email protected]
Contact: Hugo JW Fung, PhD Candidate, [email protected]
1 Studielocaties in 1 landen

Ontario

Goldring Center for High Performance Sport, Toronto, Ontario, M5S 2C9, Canada
Hugo JW Fung, PhD Candidate, Contact, 416-946-5620, [email protected]